Global NGS-based RNA-seq Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by NGS-based RNA-seq Revenue
• 1.4 Market by Type
  • 1.4.1 Global NGS-based RNA-seq Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 SBS
  • 1.4.3 SMRT
• 1.5 Market by Application
  • 1.5.1 Global NGS-based RNA-seq Market Share by Application: 2020 VS 2026
  • 1.5.2 Transcriptome Epigenetics
  • 1.5.3 Small RNA
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global NGS-based RNA-seq Market Perspective (2015-2026)
• 2.2 Global NGS-based RNA-seq Growth Trends by Regions
  • 2.2.1 NGS-based RNA-seq Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 NGS-based RNA-seq Historic Market Share by Regions (2015-2020)
  • 2.2.3 NGS-based RNA-seq Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 NGS-based RNA-seq Market Growth Strategy
  • 2.3.6 Primary Interviews with Key NGS-based RNA-seq Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top NGS-based RNA-seq Players by Market Size
  • 3.1.1 Global Top NGS-based RNA-seq Players by Revenue (2015-2020)
  • 3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global NGS-based RNA-seq Market Concentration Ratio
  • 3.2.1 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by NGS-based RNA-seq Revenue in 2019
• 3.3 NGS-based RNA-seq Key Players Head office and Area Served
• 3.4 Key Players NGS-based RNA-seq Product Solution and Service
• 3.5 Date of Enter into NGS-based RNA-seq Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global NGS-based RNA-seq Historic Market Size by Type (2015-2020)
• 4.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global NGS-based RNA-seq Market Size by Application (2015-2020)
• 5.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America NGS-based RNA-seq Market Size (2015-2020)
• 6.2 NGS-based RNA-seq Key Players in North America (2019-2020)
• 6.3 North America NGS-based RNA-seq Market Size by Type (2015-2020)
• 6.4 North America NGS-based RNA-seq Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe NGS-based RNA-seq Market Size (2015-2020)
• 7.2 NGS-based RNA-seq Key Players in Europe (2019-2020)
• 7.3 Europe NGS-based RNA-seq Market Size by Type (2015-2020)
• 7.4 Europe NGS-based RNA-seq Market Size by Application (2015-2020)

8 China

• 8.1 China NGS-based RNA-seq Market Size (2015-2020)
• 8.2 NGS-based RNA-seq Key Players in China (2019-2020)
• 8.3 China NGS-based RNA-seq Market Size by Type (2015-2020)
• 8.4 China NGS-based RNA-seq Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan NGS-based RNA-seq Market Size (2015-2020)
• 9.2 NGS-based RNA-seq Key Players in Japan (2019-2020)
• 9.3 Japan NGS-based RNA-seq Market Size by Type (2015-2020)
• 9.4 Japan NGS-based RNA-seq Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia NGS-based RNA-seq Market Size (2015-2020)
• 10.2 NGS-based RNA-seq Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia NGS-based RNA-seq Market Size by Type (2015-2020)
• 10.4 Southeast Asia NGS-based RNA-seq Market Size by Application (2015-2020)

11 India

• 11.1 India NGS-based RNA-seq Market Size (2015-2020)
• 11.2 NGS-based RNA-seq Key Players in India (2019-2020)
• 11.3 India NGS-based RNA-seq Market Size by Type (2015-2020)
• 11.4 India NGS-based RNA-seq Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America NGS-based RNA-seq Market Size (2015-2020)
• 12.2 NGS-based RNA-seq Key Players in Central & South America (2019-2020)
• 12.3 Central & South America NGS-based RNA-seq Market Size by Type (2015-2020)
• 12.4 Central & South America NGS-based RNA-seq Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Illumina
  • 13.1.1 Illumina Company Details
  • 13.1.2 Illumina Business Overview
  • 13.1.3 Illumina NGS-based RNA-seq Introduction
  • 13.1.4 Illumina Revenue in NGS-based RNA-seq Business (2015-2020))
  • 13.1.5 Illumina Recent Development
• 13.2 Thermo Fisher Scientific
  • 13.2.1 Thermo Fisher Scientific Company Details
  • 13.2.2 Thermo Fisher Scientific Business Overview
  • 13.2.3 Thermo Fisher Scientific NGS-based RNA-seq Introduction
  • 13.2.4 Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.2.5 Thermo Fisher Scientific Recent Development
• 13.3 Pacific Biosciences Of California
  • 13.3.1 Pacific Biosciences Of California Company Details
  • 13.3.2 Pacific Biosciences Of California Business Overview
  • 13.3.3 Pacific Biosciences Of California NGS-based RNA-seq Introduction
  • 13.3.4 Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.3.5 Pacific Biosciences Of California Recent Development
• 13.4 Qaigen
  • 13.4.1 Qaigen Company Details
  • 13.4.2 Qaigen Business Overview
  • 13.4.3 Qaigen NGS-based RNA-seq Introduction
  • 13.4.4 Qaigen Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.4.5 Qaigen Recent Development
• 13.5 F. Hoffmann-La Roche
  • 13.5.1 F. Hoffmann-La Roche Company Details
  • 13.5.2 F. Hoffmann-La Roche Business Overview
  • 13.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Introduction
  • 13.5.4 F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.5.5 F. Hoffmann-La Roche Recent Development
• 13.6 Agilent Technologies
  • 13.6.1 Agilent Technologies Company Details
  • 13.6.2 Agilent Technologies Business Overview
  • 13.6.3 Agilent Technologies NGS-based RNA-seq Introduction
  • 13.6.4 Agilent Technologies Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.6.5 Agilent Technologies Recent Development
• 13.7 Oxford Nanopore Technologies
  • 13.7.1 Oxford Nanopore Technologies Company Details
  • 13.7.2 Oxford Nanopore Technologies Business Overview
  • 13.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Introduction
  • 13.7.4 Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.7.5 Oxford Nanopore Technologies Recent Development
• 13.8 Perkinelmer
  • 13.8.1 Perkinelmer Company Details
  • 13.8.2 Perkinelmer Business Overview
  • 13.8.3 Perkinelmer NGS-based RNA-seq Introduction
  • 13.8.4 Perkinelmer Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.8.5 Perkinelmer Recent Development
• 13.9 Eurofins Scientific
  • 13.9.1 Eurofins Scientific Company Details
  • 13.9.2 Eurofins Scientific Business Overview
  • 13.9.3 Eurofins Scientific NGS-based RNA-seq Introduction
  • 13.9.4 Eurofins Scientific Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.9.5 Eurofins Scientific Recent Development
• 13.10 Gatc Biotech
  • 13.10.1 Gatc Biotech Company Details
  • 13.10.2 Gatc Biotech Business Overview
  • 13.10.3 Gatc Biotech NGS-based RNA-seq Introduction
  • 13.10.4 Gatc Biotech Revenue in NGS-based RNA-seq Business (2015-2020)
  • 13.10.5 Gatc Biotech Recent Development
• 13.11 Macrogen
  • 10.11.1 Macrogen Company Details
  • 10.11.2 Macrogen Business Overview
  • 10.11.3 Macrogen NGS-based RNA-seq Introduction
  • 10.11.4 Macrogen Revenue in NGS-based RNA-seq Business (2015-2020)
  • 10.11.5 Macrogen Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer